SE433212B - Forfarande for framstellning av 4-hydroxi-aporfin-derivat - Google Patents

Forfarande for framstellning av 4-hydroxi-aporfin-derivat

Info

Publication number
SE433212B
SE433212B SE7706488A SE7706488A SE433212B SE 433212 B SE433212 B SE 433212B SE 7706488 A SE7706488 A SE 7706488A SE 7706488 A SE7706488 A SE 7706488A SE 433212 B SE433212 B SE 433212B
Authority
SE
Sweden
Prior art keywords
hydroxy
preparing
procedure
aporphine derivatives
aporphine
Prior art date
Application number
SE7706488A
Other languages
English (en)
Other versions
SE7706488L (sv
Inventor
J Hartenstein
G Satzinger
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SE7706488L publication Critical patent/SE7706488L/sv
Publication of SE433212B publication Critical patent/SE433212B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/18Ring systems of four or more rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
SE7706488A 1976-06-04 1977-06-03 Forfarande for framstellning av 4-hydroxi-aporfin-derivat SE433212B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2625116A DE2625116C2 (de) 1976-06-04 1976-06-04 Verfahren zur Herstellung von 4-Hydroxy-aporphin-Derivaten

Publications (2)

Publication Number Publication Date
SE7706488L SE7706488L (sv) 1977-12-05
SE433212B true SE433212B (sv) 1984-05-14

Family

ID=5979808

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7706488A SE433212B (sv) 1976-06-04 1977-06-03 Forfarande for framstellning av 4-hydroxi-aporfin-derivat

Country Status (14)

Country Link
US (1) US4120964A (sv)
JP (1) JPS535169A (sv)
AU (1) AU508171B2 (sv)
BE (1) BE855412A (sv)
CH (1) CH629782A5 (sv)
DE (1) DE2625116C2 (sv)
DK (1) DK248277A (sv)
ES (1) ES459504A1 (sv)
FR (1) FR2353534A1 (sv)
GB (1) GB1521020A (sv)
IE (1) IE44937B1 (sv)
LU (1) LU77482A1 (sv)
NL (1) NL7706180A (sv)
SE (1) SE433212B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757335C3 (de) * 1977-12-22 1982-03-25 Gödecke AG, 1000 Berlin Verfahren zur O-Methylierung von Hydroxyaporphinen
DE2757281C3 (de) * 1977-12-22 1980-10-23 Goedecke Ag, 1000 Berlin Verfahren zur Herstellung von 1 -Hydroxy-Aporphinderivaten
FI68813C (fi) * 1978-08-21 1985-11-11 Dow Chemical Co Foerfarande foer framstaellning av terapeutiskt effektiva 1- och d,1-glausinfosfatsalter
DE3324090A1 (de) * 1983-07-05 1985-01-17 Basf Ag, 6700 Ludwigshafen Elektrophotographische aufzeichnungsmaterialien mit verbesserter photoempfindlichkeit
DE3324089A1 (de) * 1983-07-05 1985-01-17 Basf Ag, 6700 Ludwigshafen Elektrophotographische aufzeichnungsmaterialien mit verbesserter photoempfindlichkeit
US5156847A (en) * 1990-09-20 1992-10-20 Walter H. Lewis Wound-healing composition
US5474782A (en) * 1994-05-20 1995-12-12 Woundfast Pharmaceuticals, Inc. Wound-healing composition and method
US5659037A (en) * 1994-08-18 1997-08-19 Abbott Laboratories Process for preparing chiral tetracyclic dopaminergic compounds
DE19535762A1 (de) * 1995-09-26 1997-03-27 Basf Ag Verfahren zur Racematspaltung
US5932617A (en) * 1998-02-06 1999-08-03 Woundfast Pharmaceuticals Inc. Wound-treating composition and method
US6210680B1 (en) 1999-06-11 2001-04-03 Univera Pharmaceuticals, Inc. Method for the prevention and treatment of chronic venous insufficiency
US20030187011A1 (en) * 2001-12-20 2003-10-02 Lashuel Hilal A. Apomorphine inhibitors of amyloid-beta (Abeta) fibril formation and their use in amyloidosis based disease
TWI404536B (zh) * 2008-06-20 2013-08-11 Standard Chem & Pharm Co Ltd 阿朴芬化合物及其醫藥用途
CN105315208A (zh) * 2014-07-17 2016-02-10 中国科学院兰州化学物理研究所 阿朴菲类生物碱及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131191A (en) * 1962-08-08 1964-04-28 Smith Kline French Lab Process for the preparation of noraporphines

Also Published As

Publication number Publication date
NL7706180A (nl) 1977-12-06
LU77482A1 (sv) 1977-09-22
JPS535169A (en) 1978-01-18
FR2353534B1 (sv) 1980-03-07
IE44937L (en) 1977-12-04
BE855412A (fr) 1977-12-05
ES459504A1 (es) 1978-05-01
DK248277A (da) 1977-12-05
AU2580977A (en) 1978-12-07
US4120964A (en) 1978-10-17
CH629782A5 (de) 1982-05-14
IE44937B1 (en) 1982-05-19
DE2625116A1 (de) 1977-12-22
SE7706488L (sv) 1977-12-05
DE2625116C2 (de) 1984-01-26
FR2353534A1 (fr) 1977-12-30
AU508171B2 (en) 1980-03-13
GB1521020A (en) 1978-08-09

Similar Documents

Publication Publication Date Title
SE440791B (sv) Forfarande for upparbetning av lignitkol
NO782768L (no) Fremgangsmaate for fremstilling av alkenderivater
SE446740B (sv) Forfarande for framstellning av muramyldipeptidderivat
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
RO76589A (ro) Procedeu pentru prepararea alchilaminelor heterociclice
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
SE440772B (sv) Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
NO821848L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
NO152220C (no) Fremgangsmaate for fremstilling av sesquiterpenderivat
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
SE7704139L (sv) Forfarande for framstellning av azofergemnen
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE433220B (sv) Forfarande for framstellning av nya pregnan-derivat
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE431336B (sv) Analogiforfarande for framstellning av substituerade 8-azapurinderivat
NO773073L (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
SE431647B (sv) Forfarande for framstellning av 2-nitroimidazolderivat